Company Filing History:
Years Active: 1999-2000
Title: The Innovative Contributions of Lan Chiang in Cancer Research
Introduction
Lan Chiang is a prominent inventor based in Plymouth, MN, known for her significant contributions to cancer research. With a total of two patents to her name, she has demonstrated remarkable ingenuity in developing therapeutic methods to combat breast tumors and primary brain cancer.
Latest Patents
Chiang's latest patents showcase her innovative approaches to cancer treatment. One of her notable inventions involves insulin-like growth factor 1 receptors (IGF-1R) antisense. This composition and method aim to inhibit the growth and metastasis of breast tumors, leveraging an immunogen derived from breast tumor cells treated with an antisense oligonucleotide that is complementary to a gene or mRNA for the IGF-1R.
Another groundbreaking patent from Chiang focuses on antisense oligonucleotides and methods for treating primary brain cancer. This invention includes compositions that feature at least one antisense oligonucleotide designed to inhibit the proliferation of primary brain cancer cells. The antisense oligonucleotides are tailored to hybridize with mRNA encoding c-myb, creating a treatment protocol involving a pharmaceutical composition that effectively slows down the growth of primary brain cancer cells.
Career Highlights
Chiang's work is primarily associated with the University of Minnesota, where she has continued to push the boundaries of cancer research. Her innovative mindset and expertise in the field have made her a pivotal figure in advancing therapies for devastating conditions, such as breast tumors and primary brain cancer.
Collaborations
Throughout her career, she has collaborated with noted researchers and professionals, including Walter C. Low and Eric P. Flores. These partnerships underscore her commitment to leveraging collective expertise to further scientific advancements and improve patient outcomes.
Conclusion
Lan Chiang's contributions to cancer research illustrate the power of innovation in addressing critical health challenges. Her patents not only reflect her dedication to enhancing medical treatments but also position her as a leader in the field of research and development. As she continues her work at the University of Minnesota, her efforts are likely to yield further breakthroughs that will benefit countless individuals affected by cancer.